Friday, June 3, 2011

Chronic fatigue syndrome: life after XMRV : Nature News

 

Despite affecting an estimated 17 million people worldwide, CFS has always met with scepticism from some scientists, says Anthony Komaroff, a leading CFS researcher at the Brigham and Women's Hospital in Boston, Massachusetts. The likely fall of XMRV, he worries, will drive home that point. "That, in my mind, would be an intellectually inappropriate way to respond," he says, "because beyond XMRV there's evidence of an underlying biological process and infectious triggers that we need to understand better."

No comments: